After A Blockbuster 2014, What Will 2015 Hold For Pharmaceutical M&A?
West Monroe featured on Benzinga
Date : February 6, 2015

2014 was a banner year for mergers and acquisitions globally, but few sectors dominated the deal-making cycle like pharmaceuticals and biotech.

According to Bloomberg data, drug makers announced a record $234 billion in acquisitions last year, nearly triple 2013 volumes.

The year was marked by a string of mega-deals and serial acquirers, from Medtronic's $42.9 billion purchase of medical device manufacturer Covidien multibillion buys of Forest Laboratories and Allergan. Barely a month in to 2015, the industry shows no signs of sweating out the M&A bug.

West Monroe takes a look at the primary drivers behind pharmaceutical and biotech deals in 2014, and what they indicate for M&A over the next twelve months. Click here to view the article as it originally appeared on Benzinga.


Warming up to Solar Energy in Chicago, Cook County
View More
Related News
Author:
Date : April 7, 2017

West Monroe's Will Hinde sat down with ALM Intelligence's Laura Becker to discuss how he works with clients to create value and guide complex, large-scale business transformations.

Industry:
CommunityHealth Recognizes Firm’s Pro Bono Work in Chicago
Author:
Date : April 6, 2017
Industry:
Author:
Date : February 2, 2017
Will Hinde explains how healthcare organizations can best utilize communication technology to improve patients' customer experience via Healthcare Business News.
Industry: